天弘国证生物医药ETF发起式联接C(011041)
2025-07-17
0.4305
1.8212%
| 变动日期 |
总份额 |
较上期增减 |
较成立时增减 |
| 2025-03-31 | 231,621.99 | -4,298.44 | 202,384.59 |
| 2024-12-31 | 235,920.43 | 7,224.45 | 206,683.03 |
| 2024-09-30 | 228,695.98 | -6,030.34 | 199,458.58 |
| 2024-06-30 | 234,726.32 | 22,440.98 | 205,488.92 |
| 2024-03-31 | 212,285.34 | 4,097.83 | 183,047.94 |
| 2023-12-31 | 208,187.51 | -10,214.47 | 178,950.11 |
| 2023-09-30 | 218,401.98 | -3,883.16 | 189,164.58 |
| 2023-06-30 | 222,285.14 | 58,767.49 | 193,047.74 |
| 2023-03-31 | 163,517.65 | 14,314.11 | 134,280.25 |
| 2022-12-31 | 149,203.54 | -21,296.50 | 119,966.14 |
| 2022-09-30 | 170,500.04 | 47,047.93 | 141,262.64 |
| 2022-06-30 | 123,452.11 | 17,773.06 | 94,214.71 |
| 2022-03-31 | 105,679.05 | -5,313.09 | 76,441.65 |
| 2021-12-31 | 110,992.14 | 49,116.25 | 81,754.74 |
| 2021-09-30 | 61,875.89 | 14,406.84 | 32,638.49 |
| 2021-06-30 | 47,469.05 | 10,099.65 | 18,231.65 |
| 2021-03-31 | 37,369.40 | 8,132.00 | 8,132.00 |
| 2021-01-27 | 29,237.40 | -- | -- |
